Cargando…

Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study

BACKGROUND: People with prehypertension (120–130/80–90 mmHg) are at increased risk of progressing to hypertension. Recommendations for prehypertension include engaging in regular physical activity. We aimed to assess feasibility and acceptability and collect preliminary outcome data on ChiRunning fo...

Descripción completa

Detalles Bibliográficos
Autores principales: McDermott, Kelly, Kumar, Deepak, Goldman, Veronica, Feng, Haojun, Mehling, Wolf, Moskowitz, Judith T., Souza, Richard B., Hecht, Frederick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608185/
https://www.ncbi.nlm.nih.gov/pubmed/26471194
http://dx.doi.org/10.1186/s12906-015-0895-x
_version_ 1782395627620007936
author McDermott, Kelly
Kumar, Deepak
Goldman, Veronica
Feng, Haojun
Mehling, Wolf
Moskowitz, Judith T.
Souza, Richard B.
Hecht, Frederick M.
author_facet McDermott, Kelly
Kumar, Deepak
Goldman, Veronica
Feng, Haojun
Mehling, Wolf
Moskowitz, Judith T.
Souza, Richard B.
Hecht, Frederick M.
author_sort McDermott, Kelly
collection PubMed
description BACKGROUND: People with prehypertension (120–130/80–90 mmHg) are at increased risk of progressing to hypertension. Recommendations for prehypertension include engaging in regular physical activity. We aimed to assess feasibility and acceptability and collect preliminary outcome data on ChiRunning for people with elevated blood pressure. ChiRunning is a commercially available running program based on the mindful movements of Tai Chi, which is aimed at decreasing injury by both increasing body awareness and modifying running form. METHODS: We enrolled adults with elevated systolic (130–150 mmHg) or diastolic (80–100 mmHg) blood pressure in a 12-week pilot trial. Participants were randomized 2:1:1 to 8 weeks of: 1) intervention—a trainer-led ChiRunning group (n = 10); 2) active control—a trainer-led running group (n = 6); or 3) educational control—a self-directed running group (n = 6) and followed for 4 more weeks. The active control and educational control groups were combined for analysis. RESULTS: This study was feasible, meeting recruitment, retention and adherence goals, and acceptable to participants. Systolic and diastolic blood pressure did not change significantly over the study for either the ChiRunning or control groups. Changes in BMI over time were significantly different from zero in the ChiRunning group (p = 0.04) but not in the control group (slope for ChiRunning −0.05 [−0.1 to −0.002] vs. control −0.01 [−0.06 to 0.04], between slope difference, p = 0.22). Self-reported running-related injury (i.e. discomfort leading to a decrease in running) was similar between groups (ChiRunning, 4 [1.2 to 8.4] vs. control, 3 [0.7 to 7.1] injuries per 100 h of running, p = 0.72) although self-reported running-related discomfort (i.e. discomfort that does not lead to changes in running) trended higher in the ChiRunning group (ChiRunning, 10 [5.4 to 16.8] vs. control, 4 [1.5 to 9] reports of discomfort per 100 h of running, p = 0.06). CONCLUSION: ChiRunning appears to be a feasible and acceptable exercise program for people with elevated blood pressure. We did not find that ChiRunning had a significant impact on blood pressure or self reported injury, but did see a positive change in BMI over time. ChiRunning warrants further investigation in a larger trial. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01587183
format Online
Article
Text
id pubmed-4608185
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46081852015-10-17 Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study McDermott, Kelly Kumar, Deepak Goldman, Veronica Feng, Haojun Mehling, Wolf Moskowitz, Judith T. Souza, Richard B. Hecht, Frederick M. BMC Complement Altern Med Research Article BACKGROUND: People with prehypertension (120–130/80–90 mmHg) are at increased risk of progressing to hypertension. Recommendations for prehypertension include engaging in regular physical activity. We aimed to assess feasibility and acceptability and collect preliminary outcome data on ChiRunning for people with elevated blood pressure. ChiRunning is a commercially available running program based on the mindful movements of Tai Chi, which is aimed at decreasing injury by both increasing body awareness and modifying running form. METHODS: We enrolled adults with elevated systolic (130–150 mmHg) or diastolic (80–100 mmHg) blood pressure in a 12-week pilot trial. Participants were randomized 2:1:1 to 8 weeks of: 1) intervention—a trainer-led ChiRunning group (n = 10); 2) active control—a trainer-led running group (n = 6); or 3) educational control—a self-directed running group (n = 6) and followed for 4 more weeks. The active control and educational control groups were combined for analysis. RESULTS: This study was feasible, meeting recruitment, retention and adherence goals, and acceptable to participants. Systolic and diastolic blood pressure did not change significantly over the study for either the ChiRunning or control groups. Changes in BMI over time were significantly different from zero in the ChiRunning group (p = 0.04) but not in the control group (slope for ChiRunning −0.05 [−0.1 to −0.002] vs. control −0.01 [−0.06 to 0.04], between slope difference, p = 0.22). Self-reported running-related injury (i.e. discomfort leading to a decrease in running) was similar between groups (ChiRunning, 4 [1.2 to 8.4] vs. control, 3 [0.7 to 7.1] injuries per 100 h of running, p = 0.72) although self-reported running-related discomfort (i.e. discomfort that does not lead to changes in running) trended higher in the ChiRunning group (ChiRunning, 10 [5.4 to 16.8] vs. control, 4 [1.5 to 9] reports of discomfort per 100 h of running, p = 0.06). CONCLUSION: ChiRunning appears to be a feasible and acceptable exercise program for people with elevated blood pressure. We did not find that ChiRunning had a significant impact on blood pressure or self reported injury, but did see a positive change in BMI over time. ChiRunning warrants further investigation in a larger trial. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01587183 BioMed Central 2015-10-15 /pmc/articles/PMC4608185/ /pubmed/26471194 http://dx.doi.org/10.1186/s12906-015-0895-x Text en © McDermott et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
McDermott, Kelly
Kumar, Deepak
Goldman, Veronica
Feng, Haojun
Mehling, Wolf
Moskowitz, Judith T.
Souza, Richard B.
Hecht, Frederick M.
Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title_full Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title_fullStr Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title_full_unstemmed Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title_short Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study
title_sort training in chirunning to reduce blood pressure: a randomized controlled pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608185/
https://www.ncbi.nlm.nih.gov/pubmed/26471194
http://dx.doi.org/10.1186/s12906-015-0895-x
work_keys_str_mv AT mcdermottkelly traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT kumardeepak traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT goldmanveronica traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT fenghaojun traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT mehlingwolf traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT moskowitzjuditht traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT souzarichardb traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy
AT hechtfrederickm traininginchirunningtoreducebloodpressurearandomizedcontrolledpilotstudy